【24h】

Post-Transplant Recurrence of Focal Segmental Glomerulosclerosis in a Child With Heterozygous Mutations in NPHS1 and NPHS2

机译:NPHS1和NPHS2杂合子突变患儿的局灶节段性肾小球硬化的移植后复发。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Renal transplantation is the optimal renal replacement therapy (RRT) in children, but some primary diseases can recur after transplantation, and recurrence accounts for a significant proportion of graft losses, being second only to acute rejection. The risk of disease recurrence is highest among patients with idiopathic focal segmental glomerulosclerosis (FSGS), presumably due to a circulating permeability factor. Less is clear about the genetic forms of FSGS, where the data regarding the frequency of recurrence are rather conflicting. We present a 12-year-old girl with rapidly progressive FSGS and end-stage renal disease in her native kidneys associated with heterozygous mutations in NPHS1 and in NPHS2, suffering from early post-transplant recurrence. On the basis of reviewed literature, and until further and more conclusive evidence considering pathogenicity is provided, we propose that FSGS patients with heterozygous mutations in NPHS1 or NPHS2 should be considered as having idiopathic FSGS, and post-transplant recurrence should be anticipated.
机译:肾移植是儿童的最佳肾脏替代疗法(RRT),但是一些原发性疾病可以在移植后复发,并且复发占移植物损失的很大比例,仅次于急性排斥反应。特发性局灶性节段性肾小球硬化症(FSGS)患者的疾病复发风险最高,可能是由于循环通透性因素所致。关于FSGS的遗传形式还不清楚,因为有关FSGS复发频率的数据相当矛盾。我们介绍了一个12岁的女孩,其快速进展的FSGS和天然肾脏终末期肾脏疾病与NPHS1和NPHS2的杂合突变相关,患有早期移植后复发。在回顾文献的基础上,并且在提供更多病原性证据之前,我们建议将NPGS1或NPHS2杂合突变的FSGS患者视为特发性FSGS,并应预期移植后复发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号